OBJECTIVE	We tested the hypothesis that perindopril , an angiotensin-converting enzyme inhibitor with a gradual onset of action and a minimal first-dose hypotensive effect , lowers blood pressure without adversely affecting cerebral blood flow in patients 2 to 7 days after symptoms of cerebral infarction .\